Generic and Biosimilar Cancer Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£17K-£11M
Sector
HEALTH
Published
21 Apr 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 67 suppliers

Description

This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each awarded Lot is contained in section II.2 of this Notice.

Lot Division

1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

12 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

17 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

18 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

19 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

20 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

21 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

23 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.

24 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

25 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

26 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

27 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

28 Aprepitant Capsules

Supply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.

31 Octreotide Injection

Supply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier.

32 Filgrastim Pre-Filled Syringe

Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

33 Pemetrexed Powder For Solution For Infusion Vials

Supply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework.

34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

37 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework award

38 Dasatinib Tablets

Supply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants.

39 Unranked Multi-Supplier Generic & Biosimilar Medicines

Supply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier award

40 Idarubicin Hydrochloride Solution for Infusion

Supply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier.

41 Single Supplier Generic Medicines

Supply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.

Award Detail

1 Accord (Devon)
  • Lot 1 Bendamustine Powder For Solution For Infusion
  • Reference: 011419-2023-1
  • Value: £94,841
2 Accord (Devon)
  • Lot 2 Capecitabine Tablets
  • Reference: 011419-2023-2
  • Value: £748,926
3 Consilient Health (Richmond)
  • Lot 3 Carboplatin Injection
  • Reference: 011419-2023-3
  • Value: £594,456
4 Accord (Devon)
  • Lot 4 Cisplatin Injection
  • Reference: 011419-2023-4
  • Value: £205,855
5 Sandoz (Camberley)
  • Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
  • Reference: 011419-2023-5
  • Value: £255,695
6 Accord (Devon)
  • Lot 6 Cytarabine Injections
  • Reference: 011419-2023-6
  • Value: £101,689
7 Medac Pharma (Stirling)
  • Lot 7 Dacarbazine Injections
  • Reference: 011419-2023-7
  • Value: £593,020
8 Medac Pharma (Stirling)
  • Lot 8 Disodium Folinate Injection
  • Reference: 011419-2023-8
  • Value: £442,064
9 Consilient Health (Richmond)
  • Lot 9 Docetaxel Concentrate For Solution For Infusion
  • Reference: 011419-2023-9
  • Value: £319,866
10 Medac Pharma (Stirling)
  • Lot 10 Doxorubicin Hydrochloride Injections
  • Reference: 011419-2023-10
  • Value: £64,942
11 Accord (Devon)
  • Lot 12 Fluorouracil 50MG/ML Injection
  • Reference: 011419-2023-11
  • Value: £254,428
12 Consilient Health (Richmond)
  • Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
  • Reference: 011419-2023-12
  • Value: £101,239
13 Accord (Devon)
  • Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
  • Reference: 011419-2023-13
  • Value: £17,172
14 Accord (Devon)
  • Lot 18 Irinotecan Hydrochloride Injection
  • Reference: 011419-2023-14
  • Value: £226,125
15 Mercury Pharma Group (Croydon)
  • Lot 19 Lanreotide Injection Prefilled Syringes
  • Reference: 011419-2023-15
  • Value: £2,785,640
16 Medac Pharma (Stirling)
  • Lot 20 Methotrexate Without Preservatives Injection
  • Reference: 011419-2023-16
  • Value: £360,972
17 Rosemont Pharmaceuticals (Leeds)
  • Lot 21 Methotrexate Oral Solution
  • Reference: 011419-2023-17
  • Value: £55,538
18 Ranbaxy (London)
  • Lot 23 Oxaliplatin Vial Solution
  • Reference: 011419-2023-18
  • Value: £193,024
19 Fresenius Kabi (Runcorn)
  • Lot 24 Paclitaxel Concentrate For Intravenous Infusion
  • Reference: 011419-2023-19
  • Value: £346,754
20 Ranbaxy (London)
  • Lot 25 Temozolomide Capsules
  • Reference: 011419-2023-20
  • Value: £117,608
21 Teva (Castleford)
  • Lot 26 Vincristine Without Preservatives Injection
  • Reference: 011419-2023-21
  • Value: £132,132
22 Medac Pharma (Stirling)
  • Lot 27 Vinorelbine Injection
  • Reference: 011419-2023-22
  • Value: £54,400
23 Zentiva Pharma (London)
  • Lot 28 Aprepitant Capsules
  • Reference: 011419-2023-23
  • Value: £116,863
24 Ranbaxy (London)
  • Lot 31 Octreotide Injection
  • Reference: 011419-2023-24
  • Value: £135,446
25 Sandoz (Camberley)
  • Lot 32 Filgrastim Pre-Filled Syringe
  • Reference: 011419-2023-25
  • Value: £1,670,068
26 Ranbaxy (London)
  • Lot 33 Pemetrexed Powder For Solution For Infusion Vials
  • Reference: 011419-2023-26
  • Value: £161,249
27 Accord (Devon)
  • Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials
  • Reference: 011419-2023-27
  • Value: £232,447
28 Teva (Castleford)
  • Lot 38 Dasatinib Tablets
  • Reference: 011419-2023-28
  • Value: £528,727 [share]
  • Awarded to group of suppliers.
29 Zentiva Pharma (London)
  • Lot 38 Dasatinib Tablets
  • Reference: 011419-2023-28
  • Value: £528,727 [share]
  • Awarded to group of suppliers.
30 Accord (Devon)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
31 Baxter Healthcare (Berkshire)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
32 Celltrion Healthcare (Slough)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
33 Organon Pharmaceutical (Hertfordshire)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
34 Pfizer (Tadworth)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
35 Roche Products (Welwyn Garden City)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
36 Sandoz (Camberley)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
37 Teva (Castleford)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
38 Thornton & Ross (Huddersfield)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
39 Zentiva Pharma (London)
  • Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
  • Reference: 011419-2023-29
  • Value: £8,560,798 [share]
  • Awarded to group of suppliers.
40 Pfizer (Tadworth)
  • Lot 40 Idarubicin Hydrochloride Solution for Infusion
  • Reference: 011419-2023-30
  • Value: £110,072
41 Accord (Devon)
  • Lot 37 Etoposide Injection
  • Reference: 011419-2023-31
  • Value: £163,444 [share]
  • Awarded to group of suppliers.
42 Fresenius Kabi (Runcorn)
  • Lot 37 Etoposide Injection
  • Reference: 011419-2023-31
  • Value: £163,444 [share]
  • Awarded to group of suppliers.
43 Consilient Health (Richmond)
  • Lot 37 Etoposide Injection
  • Reference: 011419-2023-31
  • Value: £163,444 [share]
  • Awarded to group of suppliers.
44 Baxter Healthcare (Berkshire)
  • Lot 17 Ifosfamide Injection Powder For Reconstitution
  • Reference: 011419-2023-32
  • Value: £2,531,158
45 Accord (Devon)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
46 Baxter Healthcare (Berkshire)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
47 Bayer (Reading)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
48 Chugai Pharma (Turnham Green)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
49 Flexipharm Austrading (Bourne End)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
50 Fresenius Kabi (Runcorn)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
51 Kent Pharmaceuticals (Ashford)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
52 Martindale Pharma (Romford)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
53 Medac Pharma (Stirling)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
54 Mercury Pharma Group (Croydon)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
55 Morningside Pharmaceuticals (Leicestershire)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
56 Pfizer (Tadworth)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
57 Ranbaxy (London)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
58 Sandoz (Camberley)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
59 Selective Supplies (Haywards Heath)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
60 Teva (Castleford)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
61 Zentiva Pharma (London)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
62 Intrapharm Laboratories (Maidenhead)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
63 Glenmark Pharmaceuticals Europe (Watford)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
64 Neon Healthcare (Hertford)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
65 DR Reddys Laboratories (Cambridge)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
66 Viatris UK Healthcare (Hatfield)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.
67 Aspen Pharmacare (London)
  • Lot 41 Single Supplier Generic Medicines
  • Reference: 011419-2023-33
  • Value: £11,073,623 [share]
  • Awarded to group of suppliers.

Award Criteria

Logistics 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Section II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options. The Goods within this procurement were separated and advertised as forty-one (41) categories, each of which was identified as a “Lot” Out of the 41 lots, 33 Lots have been awarded. For details of lots not awarded, or details of individual lines awarded within a lot contact the named person at head of notice (SC Ref:723470)

Reference

Domains